A 29-year-old Mexican female was referred for evaluation of a left-sided adrenal mass noted at imaging during a medical evaluation for abdominal pain. She received prednisone from age 6 to 16 years, but she was not aware of her diagnosis and had not received glucocorticoid therapy for 13 years. Her history was notable for ambiguous genitalia, primary amenorrhea, and recurrent urinary tract infections. The physical examination was notable for short stature (134 cm, -4.9 standard deviation), hirsutism (FerrimanGallwey score of 13), hyperpigmentation, Tanner stage 2 breasts, left lower quadrant tenderness, and clitoromegaly (clitoral index: 378 mm 2 ; normal: ,35 mm 2 ) with a small, single perineal opening.
Adrenal computed tomography showed a lobulated, enhanced left adrenal mass measuring 10 3 7 cm that was compressing the left kidney. The upper portion of the mass was of lower density, suggestive of fat (264 Hounsfield units). The right adrenal was enlarged with a lowdensity mass measuring 4 3 5 cm. An Lipid-rich adrenal tumors are usually benign, and they rarely demonstrate increased uptake on 18 F-FDG PET scans, a sign of a hormone-secreting tumor. Myelolipoma, the most common fat-containing tumor of the adrenal gland, is an admixture of fatty, adenomatous, and hematopoietic tissues. These benign tumors are rare but are seen with increased frequency in patients with CAH, especially in poor disease control states and often bilaterally. This case demonstrates that unlike other fat-containing benign tumors, hormonally inactive myelolipomas rarely show increased uptake on 18 F-FDG-PET scan when the metabolically active adenomatous and hematopoietic components are extensive.
Myelolipoma should be in the differential for a large adrenal mass with increased uptake on 18 F-FDG PET scan. The presence of large, metabolically active, bilateral adrenal masses should raise suspicion for CAH, especially in a patient with clinical signs of excess androgen.
